CSF NPY immunoreactivity has been demonstrated to be higher ictally in patients with migraine compared to controls in one study [252], although this study was in contrast to a former one which did not find altered CSF NPY reactivity in suboccipital CSF [251]. This evidence concerns the gene NPY and migraine disorder.